Ursula Kienzl

Title: Ursula Kienzl: Innovator in Peptide Synthesis

Introduction

Ursula Kienzl is a prominent inventor based in Zurich, Switzerland. She has made significant contributions to the field of peptide synthesis, particularly in the development of methods for creating conformationally constrained peptides and peptidomimetics. Her innovative work has implications for synthetic vaccines, showcasing her expertise in biochemistry and immunology.

Latest Patents

Ursula Kienzl holds a patent titled "Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines." This invention relates to methods for synthesizing conformationally constrained peptides and cyclic peptidomimetics. These compounds are characterized by an internal cross-link formed between the side chain of an amino acid residue or its analog and a (2S, 4S)-4-functionalized proline residue. The patent also discusses the use of these peptidomimetics as antigens, either alone or in combination with immunopotentiating delivery systems, to elicit an immune response in mammals. Additionally, it covers pharmaceutical compositions containing these innovative compounds.

Career Highlights

Ursula Kienzl is associated with Mymetics Corporation, where she continues to advance her research in peptide synthesis and vaccine development. Her work is instrumental in the ongoing efforts to create effective synthetic vaccines that can enhance immune responses.

Collaborations

Ursula has collaborated with notable colleagues such as Gerd Pluschke and John Anthony Robinson. These partnerships have contributed to the success of her research and the development of her patented technologies.

Conclusion

Ursula Kienzl's contributions to the field of peptide synthesis and vaccine development highlight her role as an innovative inventor. Her patented methods and ongoing research continue to pave the way for advancements in synthetic vaccines, demonstrating the importance of her work in the scientific community.